contact | help | sitemap

    en fr

 
 
 

 

 

 

Feature story

Novartis Pharmaceuticals Canada Inc.: Working to eliminate malaria

A Novartis Pharmaceuticals Canada Inc. employee has returned from a volunteer mission in malaria-stricken Tanzania full of hope that a program he participated in will lead to timely access to life-saving medicines.
Learn more ›

 

Press Releases

11-May-2012

16th annual Novartis Community Partnership Day sees employees volunteer at 10 Montreal-area organizations
(224 KB)

21-Dec-2011

Novartis announces termination of ALTITUDE study with Rasilez®/ Tekturna® in high-risk patients with diabetes and renal impairment
(57 KB)

04-Oct-2011

Improved Access for TOBI* PODHALER* in Québec
(96 KB)

27-Sep-2011

Seventh annual Toronto-Montreal bicycle “Ride for the Cure” raises funds for breast cancer research and inspires Novartis employees to keep themselves healthy
(79 KB)

14-Sep-2011

Health Canada approves PrLucentis* to treat vision loss resulting from diabetic macular edema (DME)
(42 KB)

13-Sep-2011

First medication for children with brain tumours approved in Canada
(83 KB)

18-Aug-2011

Health Canada approves PrLucentis* to treat vision loss resulting from retinal vein occlusion (RVO)
(38 KB)

27-Jun-2011

Tasigna* receives Canadian approval - A significant improvement over the gold standard in treating a white blood cell cancer
(92 KB)

14-Jun-2011

Novartis candidate vaccine 4CMenB shows significant potential in providing broad coverage against meningococcal serogroup B infections
(260 KB)

27-May-2011

Novartis employees contribute volunteer efforts to 15 Montreal-area organizations as part of company’s 15th annual Community Partnership Day
(275 KB)

10-Mar-2011

First oral treatment for people with multiple sclerosis approved in Canada Shown to significantly reduce relapses and slow disease progression
(95 KB)

23-Feb-2011

Health Canada Approves FLUAD®, New Influenza Vaccine for Seniors
(159 KB)


Our products

We want to improve your quality of life.



Our four pillars of corporate citizenship

Corporate citizenship ›

Corporate citizenship at Novartis Pharmaceuticals Canada Inc. rests on four pillars: patients, business conduct, people and communities, and environmental care.

 
Worldwide Sites

USA • Switzerland • Germany • France • United Kingdom

 

Grants & Donations

Read more about the grants & donations process at Novartis Pharmaceuticals Canada Inc, which includes a link to an application form

Grants & Donations

Our focus is on patients

Our focus is on patients

Novartis Pharmaceuticals Canada Inc. is dedicated to improving the patients' well-being: it’s how we define our success.

Download our corporate brochure
(2,3 MB)